SOUTH SAN FRANCISCO, Calif., Jan. 8, 2025 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company’s president and CEO, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 8:15 a.m.… Continue reading Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tag: Morgan
Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
Former Head of Global R&D at Bayer AG and an exceptional leader with a wealth of experience across biopharma Pivotal time of transition as the company prepares to start clinical development of its first-in-class lead candidate, AT-7687 in obesity AT-7687 offers a new mechanism of action, to set a new standard in obesity management COPENHAGEN,… Continue reading Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
Kimbell Royalty Partners, LP Announces Pricing of Upsized Public Offering of Common Units
FORT WORTH, Texas, Jan. 7, 2025 /PRNewswire/ — Kimbell Royalty Partners, LP (NYSE: KRP) (“Kimbell”) today announced the pricing of its upsized public offering of 10,000,000 common units representing limited partner interests, at a public offering price of $14.90 per common unit. The total gross proceeds of the offering, before underwriters’ discounts and estimated offering… Continue reading Kimbell Royalty Partners, LP Announces Pricing of Upsized Public Offering of Common Units
Envista Announces Participation in 43rd Annual J.P. Morgan Healthcare Conference
BREA, Calif., Jan. 7, 2025 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced that the company will participate in a presentation at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, from 9:45 – 10:25 am PT at the Westin St. Francis Hotel in San Francisco. There will be an… Continue reading Envista Announces Participation in 43rd Annual J.P. Morgan Healthcare Conference
Компания GSCF приобретает IBM Deutschland Kreditbank GmbH
Расширяет экосистему Connected Capital, объединяющую корпоративных и банковских партнеров для охвата всех регионов ЕС НЬЮ-ЙОРК, 7 января 2025 г. /PRNewswire/ — Компания GSCF, ведущий мировой поставщик решений в области управления оборотным капиталом, сегодня объявила о приобретении IBM Deutschland Kreditbank GmbH для расширения возможностей платформы Connected Capital под новым брендом GSCF Working Capital Bank GmbH. Этот… Continue reading Компания GSCF приобретает IBM Deutschland Kreditbank GmbH
GSCF získava v akvizícii IBM Deutschland Kreditbank GmbH
Rozšírenie ekosystému prepojeného kapitálu spoločností a bankových partnerov na pokrytie po celej EÚ NEW YORK, 7. január 2025 /PRNewswire/ – Spoločnosť GSCF, popredný svetový poskytovateľ riešení pracovného kapitálu, dnes oznámila akvizíciu IBM Deutschland Kreditbank GmbH s cieľom zlepšiť svoje možnosti Connected Capital pod novou značkou GSCF Working Capital Bank GmbH. Tento strategický krok posilňuje pozíciu… Continue reading GSCF získava v akvizícii IBM Deutschland Kreditbank GmbH
Kaleidescape Announces Promotion of Priscilla Morgan to President and Chief Operating Officer
MOUNTAIN VIEW, Calif., Jan. 7, 2025 /PRNewswire/ — Kaleidescape, maker of the ultimate movie platform, announced today that Kaleidescape has appointed Priscilla Morgan, who currently serves as Kaleidescape’s chief operating officer, to president and chief operating officer, effective immediately. Continue Reading “I have seen the company evolve at a rapid rate due to its aggressive… Continue reading Kaleidescape Announces Promotion of Priscilla Morgan to President and Chief Operating Officer
Four Seasons Appoints Keisha Smith as Executive Vice President and Chief People and Culture Officer
TORONTO, Jan. 7, 2025 /PRNewswire/ — Four Seasons, the world’s leading luxury hospitality company, announces the appointment of Keisha Smith as Executive Vice President and Chief People and Culture Officer, effective January 6, 2025. Based at the company’s corporate office in Miami, Keisha joins the Executive Leadership Team and reports directly to Four Seasons President… Continue reading Four Seasons Appoints Keisha Smith as Executive Vice President and Chief People and Culture Officer
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
The Keynote Address, entitled “Beyond Ketamine: Combined Interventional Treatment of Suicidal Depression and PTSD,” will be presented at 10:30AM PT on Sunday January 12th, 2025 Prof. David Feifel MD PHD, designated Chief Medical Innovation Officer of HOPE and Founder of the Kadima Neuropsychiatry Institute, is an international thought leader in the interventional psychiatry space NRx Pharmaceuticals… Continue reading HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
China exports push Nippon Steel to seek growth in US, India after blocked deal
“To be a ‘truly’ global steel producer, greater production capacity above current state is likely required,” said Wood Mackenzie’s Lundin. Nippon Steel is poised to expand its operations in the U.S. and India as it hunts for growth and protection from cheap Chinese exports after its bid for U.S. Steel was blocked by the White… Continue reading China exports push Nippon Steel to seek growth in US, India after blocked deal